Dr. Robert Malone
Madison, VA
Dr. Robert Malone is a physician and biochemist who pioneered mRNA vaccine technology research. He serves as CEO of R.W. Malone M.D., LLC and is a Fellow of the Royal Society of Medicine.
Biography
Guest profiles are assembled through a combination of automated analysis and editorial review of show appearances, public records and other available sources. As these profiles are a work in progress, some details may be inaccurate, outdated or incomplete. If you are this guest or notice something that needs correcting, please let us know below and we will update the profile promptly.
Dr. Robert Wallace Malone is an American physician and biochemist with extensive research and development experience in vaccines, gene therapy, bio-defense, and immunology. He received his B.S. in biochemistry from the University of California, Davis, his M.S. in biology from UC San Diego, and his M.D. from Northwestern University Feinberg School of Medicine, followed by postdoctoral studies at Harvard Medical School.
In the late 1980s, while a graduate student researcher at the Salk Institute for Biological Studies, Malone conducted landmark experiments on mRNA technology, discovering that it was possible to transfer mRNA protected by a liposome into cultured cells. He holds numerous fundamental patents in gene delivery, delivery formulations, and vaccines, including for DNA and RNA/mRNA vaccine technologies, with over 10 patents and approximately 15,000 citations of his peer-reviewed publications.
Malone has served as CEO and Principal Consultant of R.W. Malone M.D., LLC since 2001. His career has included positions as Chief Medical Officer at Alchem Laboratories, CEO and Co-founder of Atheric Pharmaceutical LLC, and academic appointments at Kennesaw State University, the University of Maryland, and UC Davis. He is a Fellow of the Royal Society of Medicine.
Malone appeared on the Kim Monson Show three times in 2022 to discuss public health policy, vaccine safety concerns, and broader issues including government overreach and economic policy. In June 2025, he was named to the Advisory Committee on Immunization Practices by Secretary of Health and Human Services Robert F. Kennedy Jr.
Books by Dr. Robert Malone
Episodes
3 appearancesSeptember 7, 2022
Evidence-Based Medicine Becomes Weapon as Physicians Face Censorship
Dr. Malone and Dr. Corbett expose medical censorship. Kenneth Timmerman shares hostage memoir. September 7, 2022.
“It seems like every, every good intent gets weaponized in some way.”
July 13, 2022
COVID Vaccine Mandates, the Great Resignation, and Medical Freedom
James Lyons-Weiler and Robert Malone examine COVID vaccine mandates, the great resignation, and child vaccination risks on Wednesday, July 13, 2022.
“Don't jab your kids. There's no sense in this. You're putting them at risk. They, you know, if they are at very, very high risk, and it's a tiny fraction of children with cystic fibrosis or cancer or whatever. For all of us, the most important thing you can do is make sure you've got access to physicians that will treat you early if you do get infected. There's many, many different effective medicines, including monoclonal antibodies, and that's the way we should be treating this right now. The vaccines are actually making the situation worse at this point. And particularly for the highly vaccinated, they are at the highest risk of death and disease now from these escape Omicron variants like BA. 5.”
March 29, 2022
Mass Formation Psychosis and the Battle for Information Control
Dr. Robert Malone explains mass formation psychosis and globalist information control. Laurel Imer discusses election integrity and free speech. March 29, 2022.
“This is a landscape in which the objective is total information control and total thought control. That is the objective. And the right wing seems somehow to have been curiously blind to what is being done to us.”
Get in Touch
About Robert Malone
Have a question, feedback, or a suggested update for this guest's profile? We'd love to hear from you.
Your message will be reviewed by our team. We may follow up via email.